Life Science Company Funding: A Discussion of Currents Stats and New Sources-Audrey Erbes, Ph.D. and Harry Wachob, Ph.D.-05/24/2011 - 8:30am

Event Information
Event Topic: 
Life Science Company Funding: A Discussion of Currents Stats and New Sources
Event Date: 
05/24/2011 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA
Speaker Information
Event Speaker: 
Audrey Erbes, Ph.D. and Harry Wachob, Ph.D.
Event Speaker Title: 
Board VP and President
Event Speaker Company: 
Bio2Device Group
Event Speaker Bio: 

Audrey Erbes, PhD, is a global life-science business development and marketing consultant, industry educator, blogger at, professional organization leader, and public speaker. Audrey originated several bioscience business development and marketing courses at the UCB and UCSC Extensions, specifically, for working industry professionals. She has 25 years of corporate managerial experience in the biopharmaceutical industry including Executive Vice President and Cofounder of Kowa Research Institute, a licensing and investment subsidiary of Kowa Company Ltd., Japan. Previously, she held both U.S. and global management responsibilities at Syntex Corporation headquartered in Palo Alto, CA in market research, product management, strategic marketing, and business development, with a special emphasis on Europe and Asia/Pacific/Canada, serving as Regional Marketing Director out of the Hong Kong office. She holds an MA and PhD in political science from the University of Florida and BA in government from Valparaiso University.

Harry Wachob, Ph.D., is the Founder and President of the Bio2Device Group. He is an experienced engineering leader in materials science, biomedical device engineering and R&D. He has directed and mentored multidisciplinary teams in solving complex technical issues in order to improve the safety, reliability, and performance of medical devices. He is currently the Managing Materials Scientist at Xoft, Inc. Previously, he was Director of Engineering for Aerogen, Inc., a biopharmaceutical company specializing in novel aerosol drug delivery. Prior to that, Harry was Managing Engineer at Exponent/Failure Analysis Associates where he guided research and development, and product failure investigations covering a broad range of medical and industrial applications. He received his engineering degrees in Materials Science & Engineering from Cornell University.

Event Details
Event Details: 

Bio2Device Group, Tuesday Morning, May 24, 2011

"Life Science Company Funding: A Discussion of Currents Stats and New Sources"
Audrey Erbes, Ph.D., VP, Bio2Device Group and Harry Wachob, President, Bio2Device Group
Date and Time: Tuesday, May 24, 2011, 8:30 am
Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library)
Cost: Free

Here’s your chance to participate in discussion with professionals on sources of funding for life science companies—status, trends and new funding sources for biotech startups who can’t access VC funds in this current economic environment. Audrey Erbes will share some statistics and she and Harry will lead discussion of participants in attendance. Share your knowledge and learn from each other. Everyone knows of the experience of their colleagues and friends as well as what they've heard at programs they have attended.